The STAT3 Inhibitor Galiellalactone Reduces IL6-Mediated AR Activity in Benign and Malignant Prostate Models
暂无分享，去创建一个
F. Claessens | G. Schaefer | W. V. van Weerden | Z. Culig | M. Puhr | J. Hoefer | H. Erb | F. Handle | F. R. Santer | R. Marques | Fabian Guggenberger | Nicla Lorito | M. Gruber | F. Santer | Rute B. Marques | Nicla Lorito